欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/4081/003
药品名称
Lenalidomide Synthon 7,5 mg
活性成分
lenalidomide 7.5 mg
剂型
Capsule, hard
上市许可持有人
Synthon B.V.
参考成员国 - 产品名称
Netherlands (NL)
Lenalidomide Fresenius kabi 7,5 mg
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Malta (MT)
Austria (AT)
Norway (NO)
许可日期
2018/08/08
最近更新日期
2024/07/11
药物ATC编码
L04AX04 lenalidomide
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
190214 NL_H_4081_001_007_DC Lenalidomide Synthon PAR
Date of last change:2024/09/06
PubAR Summary
|
190214 NL_H_4081_001_007_DC Lenalidomide Synthon summary EN
Date of last change:2024/09/06
Final SPC
|
smpc_lenalidomide_sep_2021_V006_common_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase